LH logo

LHLaboratory Corp. Of America Holdings

$262.92
$0.89
(0.34%)
Today
Closed $266.16
$3.24
(1.22%)
After Hours
Updated: 05:07 PM EDT
EarningsJul 23
Mkt Cap$21.75B
Vol483,392.00
36

Bearish Sentiment

How do you feel about LH?

News
all
press releases
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
News Placeholder
More News
News Placeholder
Strong Performance Continues at DHR's Biotechnology Unit: What's Next?
Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders up more than 30% and core revenue gains expected in 2026.
Zacks
News Placeholder
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
Why Is Pediatrix Medical Group (MD) Down 1.7% Since Last Earnings Report?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?
Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting cancer research.
Zacks
News Placeholder
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR Newswire BURLINGTON, N.C., May 29, 2026 Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate...
PR Newswire
News Placeholder
Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects
Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects PR Newswire BURLINGTON, N.C., May 28, 2026 New pharmacogenomic test detects all...
PR Newswire
News Placeholder
LH or MEDP: Which Is the Better Value Stock Right Now?
LH vs. MEDP: Which Stock Is the Better Value Option?
Zacks
News Placeholder
Labcorp to Present at the Jefferies Global Healthcare Conference
Labcorp to Present at the Jefferies Global Healthcare Conference Labcorp to Present at the Jefferies Global Healthcare Conference PR Newswire BURLINGTON, N.C., May 27, 2026 BURLINGTON, N.C., May 27, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.